1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Breast Imaging Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Technology
6.1 Ionizing Breast Imaging
6.1.1 Market Trends
6.1.2 Major Types
6.1.2.1 Mammography
6.1.2.2 Positron Emission Tomography-Computed Tomography
6.1.2.3 Molecular Breast Imaging
6.1.2.4 Positron Emission Mammography
6.1.2.5 Cone-Beam Computed Tomography
6.1.3 Market Forecast
6.2 Non-Ionizing Breast Imaging
6.2.1 Market Trends
6.2.2 Major Types
6.2.2.1 Breast Ultrasound
6.2.2.2 Breast MRI
6.2.2.3 Automated Whole-Breast Ultrasound
6.2.2.4 Breast Thermography
6.2.2.5 Electric Impedance Tomography
6.2.2.6 Optical Imaging
6.2.3 Market Forecast
7 Market Breakup by End-User
7.1 Hospitals
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Diagnostic Imaging Centers
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Ambulatory Surgical Centers
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Price Indicators
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Allengers Medical Systems Limited
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.2 Aurora Health Care Inc. (Schoen Clinic)
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.3 Canon Inc.
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.3.4 SWOT Analysis
13.3.4 Carestream Health Inc. (Onex Corporation)
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 SWOT Analysis
13.3.5 Delphinus Medical Technologies
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.6 Dilon Technologies Inc.
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.7 Fujifilm Holdings Corporation
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Financials
13.3.7.4 SWOT Analysis
13.3.8 GE Healthcare
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.8.4 SWOT Analysis
13.3.9 Hologic Inc.
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
13.3.10 Koninklijke Philips N.V.
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.10.3 Financials
13.3.10.4 SWOT Analysis
13.3.11 Micrima Limited
13.3.11.1 Company Overview
13.3.11.2 Product Portfolio
13.3.11.3 Financials
13.3.12 Planmed Oy
13.3.12.1 Company Overview
13.3.12.2 Product Portfolio
13.3.12.3 Financials
13.3.13 Siemens Healthineers AG (Cerner Corporation)
13.3.13.1 Company Overview
13.3.13.2 Product Portfolio
13.3.13.3 Financials
13.3.14 Toshiba Corporation
13.3.14.1 Company Overview
13.3.14.2 Product Portfolio
13.3.14.3 Financials
13.3.14.4 SWOT Analysis
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/